All BioIntegrate injectables are tracked by lot number (allograft ID number). The FDA requires HCT/P products under section 361 to be traceable. Lot tracking is utilized as a course of action for documenting the management and storage of a specimen from donor to collector to the final transplant destination, and the review and reporting of the final results by a Healthcare Provider.